{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:34:24Z","timestamp":1784543664906,"version":"3.55.0"},"reference-count":22,"publisher":"Japanese Circulation Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2023,11,24]]},"DOI":"10.1253\/circj.cj-23-0263","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T22:47:51Z","timestamp":1695336471000},"page":"1730-1739","source":"Crossref","is-referenced-by-count":14,"title":["Prognostic Importance of B-Type Natriuretic Peptide Level in Patients Undergoing Catheter Ablation for Atrial Fibrillation"],"prefix":"10.1253","volume":"87","author":[{"given":"Tetsuma","family":"Kawaji","sequence":"first","affiliation":[{"name":"Department of Cardiology, Mitsubishi Kyoto Hospital"},{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Shizuta","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Aizawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shushi","family":"Nishiwaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yoshizawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Hospital Organization Kyoto Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Nishiuchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tenri Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mitsubishi Kyoto Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Yokomatsu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mitsubishi Kyoto Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Miki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mitsubishi Kyoto Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the TRANQUILIZE AF Registry Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Santhanakrishnan R, Wang N, Larson MG, Magnani JW, McManus DD, Lubitz SA, et al. Atrial fibrillation begets heart failure and vice versa: Temporal associations and differences in preserved versus reduced ejection fraction. <i>Circulation<\/i> 2016; 133: 484\u2013492.","DOI":"10.1161\/CIRCULATIONAHA.115.018614"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bajaj NS, Bhatia V, Sanam K, Ather S, Hashim T, Morgan C, et al. Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in community-dwelling older adults. <i>Am J Cardiol<\/i> 2014; 114: 909\u2013913.","DOI":"10.1016\/j.amjcard.2014.05.045"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. <i>Am Heart J<\/i> 1998; 135: 825\u2013832.","DOI":"10.1016\/S0002-8703(98)70041-9"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hijazi Z, Wallentin L, Siegbahn A, Andersson U, Christersson C, Ezekowitz J, et al. N-Terminal pro\u2013B-type natriuretic peptide for risk assessment in patients with atrial fibrillation. <i>J Am Coll of Cardiol<\/i> 2013; 61: 2274\u20132284.","DOI":"10.1016\/j.jacc.2012.11.082"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hamatani Y, Iguchi M, Ueno K, Aono Y, Esato M, Tsuji H, et al. Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failure. <i>Heart<\/i> 2021; 107: 705\u2013712.","DOI":"10.1136\/heartjnl-2020-317735"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hatashi K, Tsuda T, Nomura A, Fujino N, Nohara A, Sakata K, et al. Impact of B-type natriuretic peptide level on risk stratification of thromboembolism and death in patients with nonvalvular atrial fibrillation: The Hokuriku-Plus AF Registry. <i>Circ J<\/i> 2022; 82: 1271\u20131278.","DOI":"10.1253\/circj.CJ-17-1085"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hsu LF, Ja\u00efs P, Sanders P, Garrigue S, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation in congestive heart failure. <i>N Engl J Med<\/i> 2004; 351: 2373\u20132383.","DOI":"10.1056\/NEJMoa041018"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, et al. Catheter ablation for atrial fibrillation with heart failure. <i>N Engl J Med<\/i> 2018; 378: 417\u2013427.","DOI":"10.1056\/NEJMoa1707855"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kawaji T, Shizuta S, Aizawa T, Yamagami S, Kato M, Yokomatsu T, et al. Impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failure. <i>ESC Heart Fail<\/i> 2021; 8: 670\u2013679.","DOI":"10.1002\/ehf2.13160"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kawaji T, Shizuta S, Morimoto T, Aizawa T, Yamagami S, Yoshizawa T, et al. Very long-term clinical outcomes after radiofrequency catheter ablation for atrial fibrillation: A large single-center experience. <i>Int J Cardiol<\/i> 2017; 249: 204\u2013213.","DOI":"10.1016\/j.ijcard.2017.09.023"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Date T, Yamane T, Inada K, Matsuo S, Miyanaga S, Sugimoto K, et al. Plasma brain natriuretic peptide concentrations in patients undergoing pulmonary vein isolation. <i>Heart<\/i> 2006; 92: 1623\u20131627.","DOI":"10.1136\/hrt.2005.083022"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kurosaki K, Tada H, Hashimoto T, Ito S, Miyaji K, Naito S, et al. Plasma brain natriuretic peptide concentrations as a predictor for successful catheter ablation in patients with drug-refractory atrial fibrillation. <i>Circ J<\/i> 2007; 71: 313\u2013320.","DOI":"10.1253\/circj.71.313"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Okumura Y, Watanabe I, Nakai T, Ohkubo K, Kofune T, Kofune M, et al. Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: Importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence. <i>J Cardiovasc Electrophysiol<\/i> 2011; 22: 987\u2013993.","DOI":"10.1111\/j.1540-8167.2011.02059.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Miake J, Kato M, Ogura K, Iitsuka K, Okamura A, Tomomori T, et al. Pre-ablation levels of brain natriuretic peptide are independently associated with the recurrence of atrial fibrillation after radiofrequency catheter ablation in patients with nonvalvular atrial fibrillation. <i>Heart Vessels<\/i> 2019; 34: 517\u2013526.","DOI":"10.1007\/s00380-018-1267-5"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kuck KH, Brugada J, F\u00fcrnkranz A, Metzner A, Ouyang F, Chun KR, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. <i>N Engl J Med<\/i> 2016; 374: 2235\u20132245.","DOI":"10.1056\/NEJMoa1602014"},{"key":"16","unstructured":"16. Alibay Y, Schmitt C, Beauchet A, Dubourg O, Alexandre JA, Boileau C, et al. Non-radioimmunometric NT-proBNP and BNP assays: Impact of diluent, age, gender, BMI. <i>Ann Biol Clin (Paris)<\/i> 2005; 63: 43\u201349 (in French)."},{"key":"17","unstructured":"17. Inohara T, Kim S, Pieper K, Blanco RG, Allen LA, Fonarow GC, et al. B-Type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation. <i>Heart<\/i> 2019; 105: 370\u2013377."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Naruse Y, Tada H, Sekiguchi Y, Machino T, Ozawa M, Yamasaki H, et al. Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: A mid-term follow-up. <i>Heart Rhythm<\/i> 2011; 8: 335\u2013341.","DOI":"10.1016\/j.hrthm.2010.10.047"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Machino-Ohtsuka T, Seo Y, Tada H, Ishizu T, Machino T, Yamasaki H, et al. Left atrial stiffness relates to left ventricular diastolic dysfunction and recurrence after pulmonary vein isolation for atrial fibrillation. <i>J Cardiovasc Electrophysiol<\/i> 2011; 22: 999\u20131006.","DOI":"10.1111\/j.1540-8167.2011.02049.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Zhang Y, Chen A, Song L, Li M, Chen Y, He B. Association between baseline natriuretic peptides and atrial fibrillation recurrence after catheter ablation. <i>Int Heart J<\/i> 2016; 57: 183\u2013189.","DOI":"10.1536\/ihj.15-355"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Jiang H, Wang W, Wang C, Xie X, Hou Y. Association of pre-ablation level of potential blood markers with atrial fibrillation recurrence after catheter ablation: A meta-analysis. <i>Europace<\/i> 2017; 19: 392\u2013400.","DOI":"10.1093\/europace\/euw088"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Okada M, Tanaka N, Tanaka K, Hirao Y, Yoshimoto I, Harada S, et al. Usefulness of post-procedural plasma brain natriuretic peptide levels to predict recurrence after catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction. <i>Am J Cardiol<\/i> 2021; 144: 67\u201376.","DOI":"10.1016\/j.amjcard.2020.12.057"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/87\/12\/87_CJ-23-0263\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:47:32Z","timestamp":1715575652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/87\/12\/87_CJ-23-0263\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-23-0263","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]},"article-number":"CJ-23-0263"}}